Biomarker for Pompe Disease (BioPompe)
NCT01457443 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2023-02-13
Summary
Development of a new MS-based biomarker for the early and sensitive diagnosis of Pompe disease from blood (plasma)
Conditions
- Cardiac Diseases
- Muscular Weakness
- Hepato-splenomegaly
- Lung Disease
- Obstructive Sleep Apnoea
- Macroglossia
- Cerebral Aneurysm
Sponsors & Collaborators
-
CENTOGENE GmbH Rostock
lead INDUSTRY
Principal Investigators
-
Peter Bauer, Prof. · Centogene GmbH
Eligibility
- Min Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-08-20
- Primary Completion
- 2021-12-31
- Completion
- 2021-12-31
Countries
- Germany
- India
- Sri Lanka
Study Locations
More Related Trials
-
Biomarkers of CASH
NCT04467489 ·Status: ACTIVE_NOT_RECRUITING
-
Tracking Inflammatory Cells Using Superparamagnetic Particles of Iron Oxide (SPIO) and Magnetic Resonance Imaging (MRI)
NCT01169935 ·Status: COMPLETED ·Phase: NA
-
Human Amniotic Mesenchymal Cell Secretome for Neurodegeneration and Neuroinflammation
NCT06551649 ·Status: RECRUITING ·Phase: NA
-
CARE: A Prospective Multicenter Case Study to Assess Radiation Exposure in Patients Treated With the Penumbra Coil 400
NCT02122133 ·Status: TERMINATED
-
Magnetic Resonance Imaging Screening in Li Fraumeni Syndrome
NCT01737255 ·Status: COMPLETED
-
Blood Biomarkers of Injury and Outcome in Traumatic Brain Injury
NCT01730443 ·Status: TERMINATED
-
Novel Metabolic Muscular Biomarkers in Pompe Disease - a Non-invasive Magnetic Resonance Exploratory Pilot Study.
NCT05943678 ·Status: ACTIVE_NOT_RECRUITING
-
Radiolabeled TSPO Targeted Molecular Probe in Alzheimer's Disease.
NCT07105956 ·Status: NOT_YET_RECRUITING
-
Investigation of Blood-Brain-Barrier Breakdown Using Manganese Magnetic Resonance Imaging in Drug-Resistant Epilepsy
NCT02531880 ·Status: RECRUITING ·Phase: PHASE1
-
Central Vein Sign: a Diagnostic Biomarker in Multiple Sclerosis
NCT04495556 ·Status: ACTIVE_NOT_RECRUITING
-
P-glycoprotein Function in Brain Diseases
NCT00677885 ·Status: COMPLETED
-
Rapid Diagnosis and Prognosis Recognition of Imaging and Biomarkers in Mild to Moderate Traumatic Brain Injury
NCT05108909 ·Status: UNKNOWN
-
A Functional MRI Study: Assessing Brain Function in Post Stoke Patients
NCT06573840 ·Status: WITHDRAWN ·Phase: NA
-
Detection of Brain Metastases Using a Novel Gadolinium-Weighted MRI Sequence: A Prospective Comparison
NCT07272616 ·Status: RECRUITING
-
Biomarker-Led Optimization of Successful Surgical Outcomes in Moyamoya
NCT06634004 ·Status: ENROLLING_BY_INVITATION
-
A Monocenter, Cross-sectional Study to Compare Different Type of Cognitive Impairment in Multiple Sclerosis Patients and Cerebrospinal Fluid Biomarkers (Beta Amyloid, Total Tau Protein and Tau-phosphorylated Protein).
NCT00978536 ·Status: TERMINATED ·Phase: NA
-
MRI Biomarkers for Radiation-Induced Neurocognitive Decline Following SRS of Newly Diagnosed Brain Mets
NCT04073966 ·Status: RECRUITING
-
Positron Emission Tomography Imaging of Brain Amyloid in Normal Pressure Hydrocephalus
NCT01092546 ·Status: TERMINATED ·Phase: PHASE3
-
Detecting Traumatic Intracranial Hemorrhage With Microwaves and Biomarkers
NCT04666766 ·Status: RECRUITING ·Phase: NA
-
Cell Tracking Using Superparamagnetic Particles of Iron Oxide (SPIO) and Magnetic Resonance Imaging (MRI) - A Pilot Study
NCT00972946 ·Status: COMPLETED ·Phase: NA
-
Multiomic Analysis of Traumatic Brain Injury and Hypertension Intracranial Hemorrhage Lesion Tissue
NCT05778110 ·Status: UNKNOWN
-
Permeability MRI in Cerebral Cavernous Malformations Type 1 in New Mexico: Effects of Statins
NCT01764451 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Manganese-Enhanced Magnetic Resonance Imaging in Healthy Volunteers and People With Multiple Sclerosis
NCT01326715 ·Status: COMPLETED ·Phase: PHASE1
-
A TMU/NIH Integrated Research Project Translation of Basic Research to Clinical Diagnosis and Treatment of Mild Traumatic Brain Injury (mTBI)
NCT01266356 ·Status: UNKNOWN
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA